FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000416417> ?p ?o ?g. }

• W3000416417 endingPage "393" @default.
• W3000416417 startingPage "388" @default.
• W3000416417 abstract "Abstract Background Early antiretroviral therapy (ART) is recommended for infants with human immunodeficiency virus (HIV) infection. However, few antiretroviral options are available for neonates. Methods The Early Infant Treatment Study in Botswana tested HIV-exposed infants within 96 hours of birth, and HIV-infected infants started nevirapine (NVP) 6 mg/kg twice daily, zidovudine (ZDV), and lamivudine (3TC) at age &lt; 7 days. NVP trough concentrations were tested at 1 and 2 weeks. NVP was switched to ritonavir-boosted lopinavir (LPV/r) at week 2, 3, 4, or 5 according to delivery gestational age. Results Forty HIV-infected infants started ART at median age 2 days (range, 1–5 days). NVP trough concentrations were highly variable and below therapeutic target (3000 ng/mL) for 50% of 2-week measurements; concentrations did not correlate with viral decline at weeks 2, 4, or 12. Two deaths unrelated to ART occurred through 24 weeks. Only 1 unscheduled treatment modification was required. Within 4 weeks of transition to LPV/r, 9 (22.5%) had transient HIV RNA increases, likely due to poor LPV/r palatability. At 12 weeks, 22 (55%) of 40 were &lt;40 copies/mL (93% &lt;400 copies/mL); by 24 weeks, 27 of 38 (71%) were &lt; 40 copies/mL (84% &lt; 400 copies/mL). HIV-1 RNA response at 12 and 24 weeks did not differ by baseline HIV RNA or other factors. Conclusions NVP/ZDV/3TC started in the first week of life was safe and effective, even when trough NVP levels were below target. Transient viral increases occurred following transition to LPV/r, but by 12 and 24 weeks most children achieved and maintained viral suppression. Clinical Trials Registration NCT02369406." @default.
• W3000416417 created "2020-01-23" @default.
• W3000416417 creator A5010906104 @default.
• W3000416417 creator A5019085141 @default.
• W3000416417 creator A5019383174 @default.
• W3000416417 creator A5020405624 @default.
• W3000416417 creator A5024029270 @default.
• W3000416417 creator A5030501259 @default.
• W3000416417 creator A5032863083 @default.
• W3000416417 creator A5040076878 @default.
• W3000416417 creator A5050589978 @default.
• W3000416417 creator A5051222792 @default.
• W3000416417 creator A5057590991 @default.
• W3000416417 creator A5058715015 @default.
• W3000416417 creator A5077967172 @default.
• W3000416417 creator A5089498228 @default.
• W3000416417 creator A5089772409 @default.
• W3000416417 date "2020-01-12" @default.
• W3000416417 modified "2023-10-16" @default.
• W3000416417 title "Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life" @default.
• W3000416417 cites W1517608807 @default.
• W3000416417 cites W1940770670 @default.
• W3000416417 cites W1969598330 @default.
• W3000416417 cites W1975978056 @default.
• W3000416417 cites W2002432974 @default.
• W3000416417 cites W2004943035 @default.
• W3000416417 cites W2028099639 @default.
• W3000416417 cites W2040631907 @default.
• W3000416417 cites W2054937433 @default.
• W3000416417 cites W2076646492 @default.
• W3000416417 cites W2081872889 @default.
• W3000416417 cites W2122846238 @default.
• W3000416417 cites W2126156212 @default.
• W3000416417 cites W2135390958 @default.
• W3000416417 cites W2135892517 @default.
• W3000416417 cites W2141810510 @default.
• W3000416417 cites W2183262022 @default.
• W3000416417 cites W2335025772 @default.
• W3000416417 cites W2335427248 @default.
• W3000416417 cites W2416750587 @default.
• W3000416417 cites W2476161020 @default.
• W3000416417 cites W2549685936 @default.
• W3000416417 cites W2592985839 @default.
• W3000416417 cites W2613806227 @default.
• W3000416417 cites W2623665829 @default.
• W3000416417 cites W2689870615 @default.
• W3000416417 cites W2884612883 @default.
• W3000416417 cites W2887863528 @default.
• W3000416417 cites W2899670891 @default.
• W3000416417 cites W2950993997 @default.
• W3000416417 doi "https://doi.org/10.1093/cid/ciaa028" @default.
• W3000416417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7850532" @default.
• W3000416417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31927562" @default.
• W3000416417 hasPublicationYear "2020" @default.
• W3000416417 type Work @default.
• W3000416417 sameAs 3000416417 @default.
• W3000416417 citedByCount "16" @default.
• W3000416417 countsByYear W30004164172021 @default.
• W3000416417 countsByYear W30004164172022 @default.
• W3000416417 countsByYear W30004164172023 @default.
• W3000416417 crossrefType "journal-article" @default.
• W3000416417 hasAuthorship W3000416417A5010906104 @default.
• W3000416417 hasAuthorship W3000416417A5019085141 @default.
• W3000416417 hasAuthorship W3000416417A5019383174 @default.
• W3000416417 hasAuthorship W3000416417A5020405624 @default.
• W3000416417 hasAuthorship W3000416417A5024029270 @default.
• W3000416417 hasAuthorship W3000416417A5030501259 @default.
• W3000416417 hasAuthorship W3000416417A5032863083 @default.
• W3000416417 hasAuthorship W3000416417A5040076878 @default.
• W3000416417 hasAuthorship W3000416417A5050589978 @default.
• W3000416417 hasAuthorship W3000416417A5051222792 @default.
• W3000416417 hasAuthorship W3000416417A5057590991 @default.
• W3000416417 hasAuthorship W3000416417A5058715015 @default.
• W3000416417 hasAuthorship W3000416417A5077967172 @default.
• W3000416417 hasAuthorship W3000416417A5089498228 @default.
• W3000416417 hasAuthorship W3000416417A5089772409 @default.
• W3000416417 hasBestOaLocation W30004164171 @default.
• W3000416417 hasConcept C126322002 @default.
• W3000416417 hasConcept C142462285 @default.
• W3000416417 hasConcept C203014093 @default.
• W3000416417 hasConcept C2522874641 @default.
• W3000416417 hasConcept C2777182164 @default.
• W3000416417 hasConcept C2777869810 @default.
• W3000416417 hasConcept C2778376644 @default.
• W3000416417 hasConcept C2779130552 @default.
• W3000416417 hasConcept C2779234561 @default.
• W3000416417 hasConcept C2780216070 @default.
• W3000416417 hasConcept C2780593183 @default.
• W3000416417 hasConcept C2780727368 @default.
• W3000416417 hasConcept C2781392899 @default.
• W3000416417 hasConcept C2781432083 @default.
• W3000416417 hasConcept C2993143319 @default.
• W3000416417 hasConcept C3013748606 @default.
• W3000416417 hasConcept C54355233 @default.
• W3000416417 hasConcept C71924100 @default.
• W3000416417 hasConcept C86803240 @default.
• W3000416417 hasConceptScore W3000416417C126322002 @default.
• W3000416417 hasConceptScore W3000416417C142462285 @default.

• next